Vicarious Surgical Inc. reported its fourth quarter and full year financial results for 2024 on March 17, 2025, highlighting an improved net loss for the full year.
The company's net loss for the full year 2024 was $(63,223) thousand, an improvement from $(71,071) thousand in 2023, while the fourth quarter 2024 net loss was $(13,926) thousand compared to $(13,111) thousand in the prior year period.
Vicarious Surgical achieved its 2024 cash burn guidance with a rate of $49 million and set its full-year 2025 cash burn guidance at approximately $50 million.
As of December 31, 2024, cash, cash equivalents, and short-term investments totaled $49,097 thousand.
The company announced the successful completion of the integration of its Version 1.0 System and expanded strategic hospital partnerships with LSU Health New Orleans, Temple Health, and University of Illinois Health.
CEO Adam Sachs stated the company's focus for 2025 is on preparing for its first clinical patients later in the year, diligently building inventory and securing Institutional Ethics Committee site approvals.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.